The pharmacokinetics of oxypurinol in people with gout
Sophie L. Stocker(University of California, San Francisco), Richard O. Day(St Vincent's Hospital Sydney), Garry G. Graham(UNSW Sydney), Andrew J. McLachlan(The University of Sydney), Kenneth M. Williams(UNSW Sydney), Carl M. J. Kirkpatrick(National Council for Palliative Care), Radojka M. Savić(University of California, San Francisco)
Cited by 33
Related Papers
Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes
|Journal of Clinical Epidemiology|2012|1.2k
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
|New England Journal of Medicine|2021|548
Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis
|BMJ Open|2016|527
Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies
|Thrombosis and Haemostasis|2014|467